Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
MS: COVID-19, uitgesteld doseren natalizumab en nieuwe middelen
dec 2020 | Multipele Sclerose